Come up with a name for your new list and we'll add to it:
Blackthorn Therapeutics raised a round of funding on January 29, 2014. Investors include
ARCH Venture Partners.
Blackthorn Therapeutics is developing targeted medicines for neurodevelopmental disorders. BlackThorn leverages its INFORM platform, which supports the discovery and development of targeted treatments…